Athar M. Qureshi, MD
- Cardiology
Medical Director, CE Mullins Cardiac Catheterization Laboratories
Program Director, Interventional Cardiology Fellowship, CE Mullins Cardiac Catheterization Laboratories
Professor of Pediatrics, Baylor College of Medicine
Phone:
832-824-3278
Cardiology
Fax:
832-826-4297
Languages: English
Office locations:
6651 Main Street
Houston, TX 77030
Get to know Athar M. Qureshi, MD
Dr. Qureshi is the Medical Director of The CE Mullins Cardiac Catheterization Laboratories at Texas Children’s Hospital and a Professor of Pediatrics at The Baylor College of Medicine. He is board certified in both Pediatric Cardiology and Adult Congenital Heart Disease.
Dr. Qureshi believes it is an honor and privilege to take care of patients with congenital heart disease and their families. He is involved in numerous national and international studies focused on developing innovative therapies that can be applied to interventional cardiology. His clinical and research interests include pulmonary vein stenosis, fetal cardiac interventions, patent ductus arteriosus (PDA) stenting, recanalization of occluded vessels, transcatheter valve therapy, and catheter-based therapies for heart failure. He is also extremely passionate about educating the future generation of healthcare professionals.
Outside of work, Dr. Qureshi enjoys spending time with his wife and three children. He is an avid fan of cricket and soccer.
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Boston Children's Hospital/Harvard Medical School | Fellowship | Interventional Cardiology | 2005 |
| Cleveland Clinic | Fellowship | Pediatric Cardiology | 2004 |
| UH Rainbow Babies and Children's Hospital | Fellowship | Pediatric Cardiology | 2002 |
| SUNY Downstate Medical Center | Residency | Pediatrics | 2001 |
| The Aga Khan University | MBBS | Bachelor of Medicine, Bachelor or Surgery | 1996 |
Organizations
| Organization Name | Role |
|---|---|
| American College of Cardiology | Fellow |
| American Academy of Pediatrics | Fellow |
| Society for Cardiovascular Angiography and Interventions Foundation | Fellow |
| Congenital Cardiac Research Collaborative | Executive Committee Member |
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Qureshi AM, Turner ME, O'Neill W, Denfield SW, Aghili N, Badiye A, Gandhi R, Tehrani B, Chang G, Oyama JK, Sinha S, Brozzi N, Morray B. Percutaneous Impella RP use for refractory right heart failure in adolescents and young adults-A multicenter U.S. experience. Catheter Cardiovasc Interv 2020 Aug;96(2):376-381. doi: 10.1002/ccd.28830. Epub 2020 Mar 4. PubMed PMID: 32129576.
Morray BH, Dimas VV, McElhinney DB, Puri K, Qureshi AM. Patient size parameters to guide use of the Impella device in pediatric patients. Catheter Cardiovasc Interv 2019 Oct 1;94(4):618-624. doi: 10.1002/ccd.28456. Epub 2019 Aug 19. PubMed PMID: 31424167.
Aggarwal V, Dhillon GS, Penny DJ, Gowda ST, Qureshi AM. Drug-Eluting Stents Compared With Bare Metal Stents for Stenting the Ductus Arteriosus in Infants With Ductal-Dependent Pulmonary Blood Flow. Am J Cardiol 2019 Sep 15;124(6):952-959. doi: 10.1016/j.amjcard.2019.06.014. Epub 2019 Jun 26. PubMed PMID: 31350000.
Qureshi AM, Goldstein BH, Glatz AC, Agrawal H, Aggarwal V, Ligon RA, McCracken C, McDonnell A, Buckey TM, Whiteside W, Metcalf CM, Petit CJ. Classification scheme for ductal morphology in cyanotic patients with ductal dependent pulmonary blood flow and association with outcomes of patent ductus arteriosus stenting. Catheter Cardiovasc Interv 2019 Apr 1;93(5):933-943. doi: 10.1002/ccd.28125. Epub 2019 Feb 21. PubMed PMID: 30790426.
Qureshi AM, Bansal N, McElhinney DB, Boudjemline Y, Forbes TJ, Maschietto N, Shahanavaz S, Cheatham JP, Krasuski R, Lamers L, Chessa M, Morray BH, Goldstein BH, Noel CV, Wang Y, Gillespie MJ. Branch Pulmonary Artery Valve Implantation Reduces Pulmonary Regurgitation and Improves Right Ventricular Size/Function in Patients With Large Right Ventricular Outflow Tracts. JACC Cardiovasc Interv 2018 Mar 26;11(6):541-550. doi: 10.1016/j.jcin.2018.01.278. PubMed PMID: 29566799.
Aggarwal V, Mulukutla V, Maskatia S, Justino H, Mullins CE, Qureshi AM. Outcomes after Balloon Pulmonary Valvuloplasty for Critical Pulmonary Stenosis and Incidence of Coronary Artery Fistulas. Am J Cardiol 2018 Jun 15;121(12):1617-1623. doi: 10.1016/j.amjcard.2018.02.049. Epub 2018 Mar 13. PubMed PMID: 29681368.
Glatz AC, Petit CJ, Goldstein BH, Kelleman MS, McCracken CE, McDonnell A, Buckey T, Mascio CE, Shashidharan S, Ligon RA, Ao J, Whiteside W, Wallen WJ, Metcalf CM, Aggarwal V, Agrawal H, Qureshi AM. Comparison Between Patent Ductus Arteriosus Stent and Modified Blalock-Taussig Shunt as Palliation for Infants With Ductal-Dependent Pulmonary Blood Flow: Insights From the Congenital Catheterization Research Collaborative. Circulation 2018 Feb 6;137(6):589-601. doi: 10.1161/CIRCULATIONAHA.117.029987. Epub 2017 Oct 17. PubMed PMID: 29042354.
